3D Medical Imaging Devices Market Report 2025

This 3D Medical Imaging Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The 3D medical imaging devices market size has grown strongly in recent years. It will grow from $12.45 billion in 2024 to $13.35 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to improved diagnostic accuracy, minimally invasive procedures, aging population, personalized medicine.

The 3D medical imaging devices market size is expected to see strong growth in the next few years. It will grow to $18.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging markets growth, regulatory support, artificial intelligence (ai) and machine learning, early detection and intervention. Major trends in the forecast period include liquid biopsies, multi-omics approaches, point-of-care testing, screening and early intervention campaigns.

The growth of the 3D medical imaging market is significantly influenced by the rising incidence of injuries, particularly sports-related injuries. This increase in sports-related injuries can be attributed to the growing participation of individuals in both organized and informal sports activities. Furthermore, the training of athletes with a focus on high strength and heavy loads also leads to a higher occurrence of severe injuries. Sports injuries, in particular, are often characterized by soft tissue damage. The utilization of 3D medical imaging devices such as ultrasound, X-ray, and MRI imaging plays a crucial role in providing accurate and objective diagnostic support. 3D medical imaging devices enable healthcare professionals to examine and diagnose various types of injuries, including muscle fascia injuries, tendon injuries, ligament injuries, meniscus injuries, articular cartilage issues, and bone fractures. According to data from the Centre for Disease Control and Prevention, there are approximately 775,000 emergency room visits each year attributed to injuries sustained by children participating in organized and unorganized sports activities. This underscores the growing demand for 3D medical imaging devices, which in turn drives the market's growth.

The anticipated growth of the 3D medical imaging market is strongly influenced by the escalating prevalence of chronic diseases. Chronic diseases, characterized by long-lasting health conditions persisting for three months or more, represent a significant health challenge globally. Techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI) within the realm of 3D medical imaging play a crucial role in offering comprehensive, three-dimensional insights into internal structures. This enables healthcare professionals to detect and diagnose chronic diseases at earlier, more treatable stages. For instance, statistics from the World Health Organization's 2022 Highlights reveal that chronic diseases account for approximately 74% of global annual deaths, totaling around 41 million deaths. Moreover, according to data from the National Library of Medicine in January 2023, the number of individuals aged 50 and older in the United States with at least one chronic condition is projected to rise by a significant 99.5% to reach approximately 142.66 million by the year 2050. These rising numbers and the substantial impact of chronic diseases underscore the critical need for advanced medical imaging technologies. As such, the increasing prevalence of chronic conditions serves as a driving force behind the growth of the 3D medical imaging market.

Manufacturers of 3D medical imaging devices are increasingly directing their investments towards Artificial Intelligence (AI) to enhance diagnostic accuracy by providing precise, quantifiable measurements. AI integration offers notable efficiency in medical imaging, particularly in the detection of organs or anomalies. An illustrative example is in cardiology, where the amalgamation of image visualization and AI enables cardiologists to accurately measure ejection fraction - a crucial indicator of heart health - swiftly and with high precision. Ejection fraction signifies the percentage of blood leaving the heart during each contraction. For instance, in November 2021, GE Healthcare, a prominent company in the realm of 3D imaging devices, introduced 60 innovative technology solutions. These solutions incorporate artificial intelligence to revolutionize healthcare, offering patients and clinicians effective tools for improved diagnostic accuracy and streamlined processes.

Leading companies in the 3D medical imaging market are actively pioneering innovative immersive learning platforms to offer enhanced and reliable services to their clientele. An immersive learning platform in the domain of 3D medical imaging utilizes hyper-realistic visuals derived from MRI and CT scans to educate medical professionals and students. For example, in August 2023, GigXR, Inc., a U.S.-based innovative company specializing in holographic training solutions, introduced the DICOM XR Library. This library serves as a shared repository of 3D DICOM holograms, offering hyper-realistic 3D medical images sourced from computed tomography (CT) scans and magnetic resonance imaging (MRI). These holograms enable diagnostic imaging in a 360-degree format, providing instructors with an advanced tool to better equip learners with medically precise simulations for observation and assessment. This technology facilitates a more immersive and effective learning experience for medical professionals and students within the field of 3D medical imaging.

In January 2024, GE HealthCare Technologies, Inc., a US-based manufacturer of 3D medical imaging devices, acquired MIM Software Inc. for an undisclosed amount. This acquisition reflects GE HealthCare's strategy to enhance its portfolio by leveraging MIM Software's expertise in 3D medical imaging solutions. MIM Software Inc. is a US-based company specializing in 3D medical imaging devices.

3D medical imaging represents an advanced optical technology that generates magnified internal body images for precise medical analysis. This imaging method employs computer-aided design (CAD) or magnetic resonance imaging (MRI) to create a three-dimensional visual representation of bodily structures.

The primary modalities within 3D medical imaging include ultrasound, X-ray, CT scans, and other techniques. X-rays specifically produce 2D images that simulate a 3D perspective in imaging. This technology finds applications in gynecology, obstetrics, cardiology, neurology, orthopedics, and oncology, catering to diverse end-users such as diagnostic centers, hospitals, and research facilities.

The 3D medical imaging market research report is one of a series of new reports that provides 3D medical imaging market statistics, including 3D medical imaging industry global market size, regional shares, competitors with a 3D medical imaging market share, detailed 3D medical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the 3D medical imaging industry. This 3D medical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the 3d medical imaging devices market include GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Materialise NV, Toshiba Group, Samsung Medison Co Ltd, Shimadzu Corporation, Analogic Corporation, Digirad Corporation, Del Medical Systems Group, Hologic Inc., Carestream Health Inc., Depuy Synthes Companies, Ambra Health, Fovia, Mach7 Technologies Ltd., Medtronic plc, Barco NV, TomTec Imaging Systems GmbH, Fujifilm Holdings Corporation, 3D Systems Healthcare, Artec 3D, Canon Medical Systems Corporation, ContextVision AB, Curvebeam AI Ltd., EchoPixel Inc., EOS Imaging, Esaote SpA, Hitachi Healthcare, Intrasense, KaVo Kerr, Konica Minolta Healthcare, Mobius Imaging, Neusoft Medical Systems, Orfit Industries, Pie Medical Imaging, Planmed Oy, Sectra, Shenzhen Mindray Bio-Medical Electronics, Thermo Fisher Scientific, Varian Medical Systems, Ziehm Imaging GmbH.

Western Europe was the largest region in the 3D medical imaging market in 2024. Asia-Pacific was the second-largest region in the global 3D medical imaging devices market. The regions covered in the 3d medical imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D medical imaging devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The 3D medical imaging market consists of sales of ultrasound, magnetic resonance imaging (MRI), radiography, and computed tomography scan (CT). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.